CD4 and cancer: DCs have a unique ability to uptake, process and express cancer antigens on their surface in the complex with the major histocompatibility complex (MHC) class I and II, to migrate to secondary lymph tissue where they induce activation of naïve cancer antigen-specific CD4 and CD8 T cells and their differentiation into effector cells.